Intermediate filament diseases: Desminopathy

Advances in Experimental Medicine and Biology

Volumn 642, Issue , 2008, Pages 131-164

  Goldfarb, Lev G ^a   Olivé, Montse ^b   Vicart, Patrick ^c   Goebel, Hans H ^d  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c Lab Cogn et Developpement   (France)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CRYSTALLIN; DESMIN;

ANIMAL; ARTICLE; DISEASE COURSE; GENETICS; HUMAN; INTERMEDIATE FILAMENT; METABOLISM; MUSCLE DISEASE; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ALPHA-CRYSTALLIN B CHAIN; ANIMALS; DESMIN; DISEASE PROGRESSION; HUMANS; INTERMEDIATE FILAMENTS; MUSCULAR DISEASES; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 60549106181     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-84847-1_11     Document Type: Article

References (119)

1. Goebel HH, Voit T, Warlo I et al. Immunohistologic and electron microscopic abnormalities of desmin and dystrophin in familial cardiomyopathy and myopathy. Rev Neurol (Paris) 1994; 150:452-459. (Pubitemid 24254848)
2. Selcen D, Ohno K, Engel AG. Myofibrillar myopathy: Clinical, morphological and genetic studies in 63 patients Brain 2004; 127:439-451. (Pubitemid 38160328)
3. Park KY, Dalakas MC, Goebel HH et al. Desmin splice variants causing cardiac and skeletal myopathy. J Med Genet 2000; 37:851-857.
4. Goudeau B, Dagvadorj A, Rodrigues-Lima F et al. Structural and functional analysis of a new desmin variant causing desmin-related myopathy. Hum Mutation 2001; 18:388-396. (Pubitemid 33055008)
5. Bar H, Strelkov SV, Sjoberg G et al. The biology of desmin filaments: How do mutations affect their structure, assembly and organization. J Struct Biol 2004; 148:137-152. (Pubitemid 39346004)
6. Sjoberg G, Saavedra-Matiz CA, Rosen DR et al. Missense mutation in the desmin rod domain is associated with autosomal dominant distal myopathy and exerts a dominant negative effect on filament formation. Hum Mol Genet 1999; 8:2191-2198. (Pubitemid 29525333)
7. Wang X, Osinska H, Dorn GW II et al. Mouse model of desmin-related cardiomyopathy. Circulation 2001; 103:2402-2407. (Pubitemid 32448807)
8. Vicart P, Caron A, Guicheney P et al. A missense mutation in the alpha-B-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet 1998; 20:92-95. (Pubitemid 28410353)
9. Goldfarb LG, Park KY, Cervenakova L et al. Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet 1998; 19:402-403. (Pubitemid 28357917)
10. Muñoz-Mármol AM, Strasser G, Isamat M et al. A dysfunctional desmin mutation in a patient with severe generalized myopathy. Proc Nat Acad Sci 1998; 95:11312-11317. (Pubitemid 28450125)
11. Dalakas MC, Park K-Y, Semino-Mora C et al. Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N Engl J Med 2000; 342:770-780. (Pubitemid 30151921)
12. Wang X, Osinska H, Klevitsky R et al. Expression of R120G-aB-crystallin causes aberrant desmin and aB-crystallin aggregation and cardiomyopathy in mice. Circ Res 2001; 89:84-91. (Pubitemid 34135496)
13. Wilhelmsen KC, Blake DM, Lynch T et al. Chromosome 12-linked autosomal dominant scapuloperoneal muscular dystrophy. Ann Neurol 1996; 39:507-520. (Pubitemid 26118006)
14. Melberg A, Oldfors A, Blomstrom-Lundqvist C et al. Autosomal dominant myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy linked to chromosome 10q. Ann Neurol 1999; 46:684-692. (Pubitemid 29518128)
15. Selcen D, Engel AG. Myofibrillar myopathy. GeneReviews (http://www.genereviews.org/) 2006.
16. Fuchs E, Weber K. Intermediate filaments: Structure, dynamics, function and disease. Annu Rev Biochem 1994; 63:345-382.
17. Herrmann H, Aebi U. Intermediate filaments: Molecular structure, assembly mechanism and integration into functionally distinct intracellular scaffolds. Annu Rev Biochem 2004; 73:749-789. (Pubitemid 39050385)
18. Lazarides E. Intermediate filaments as mechanical integrators of cellular space. Nature 1980; 238:249-256. (Pubitemid 10177899)
19. Schroder R, Furst DO, Klasen C et al. Association of plectin with Z-discs is a prerequisite for the formation of the intermyofibrillar desmin cytoskeleton. Lab Invest 2000; 80:455-464. (Pubitemid 30226627)
20. Price MG. Molecular analysis of intermediate filament cytoskeleton-Putative load-bearing structure. Am J Physiol 1984; 246:566-572.
21. Li Z, Colucci-Guyon E, Pinçon-Raymond M et al. Cardiovascular lesions and skeletal myopathy in mice lacking desmin. Dev Biol 1996; 175:362-366. (Pubitemid 26160764)
22. Capetanaki Y, Milner DJ, Weitzer G. Desmin in muscle formation and maintenance: Knockouts and consequences. Cell Struct Funct 1997; 22:103-116. (Pubitemid 27223251)
23. Milner DJ, Weitzer G, Tran D et al. Disruption of muscle architecture and myocardial degeneration in mice lacking desmin. J Cell Biol 1996; 134:1255-1270. (Pubitemid 26300170)
24. Golenhofen N, Arbeiter A, Koob R et al. Ischemia-induced association of the stress protein alpha B-crystallin with I-band portion of cardiac titin. J Mol Cell Cardiol 2002; 34:309-319. (Pubitemid 37162423)
25. Bullard B, Ferguson C, Minajeva A et al. Association of the chaperone alphaB-crystallin with titin in heart muscle. J Biol Chem 2004; 279:7917-7924. (Pubitemid 38294679)
26. Inagaki N, Hayashi T, Arimura T. Alpha B-crystallin mutation in dilated cardiomyopathy. Biochem Biophys Res Commun 2006; 342:379-386. (Pubitemid 43289005)
27. Viegas-Péquignot E, Li Z, Dutrillaux B et al. Assignment of human desmin gene to band 2q35 by nonradioactive in situ hybridization. Hum Genet 1989; 83:33-36. (Pubitemid 19206038)
28. Li Z, Lilienbaum A, Butler-Browne G et al. Human desmin-coding gene: Complete nucleotide sequence, characterization and regulation of expression during myogenesis and development. Gene 1989: 78:243-254 (Pubitemid 19154203)
29. Weber K, Geisler N. Intermediate filaments: Structural conservation and divergence. Ann NY Acad Sci 1985; 455:126-143. (Pubitemid 16145363)
30. Brown JH, Cohen C, Parry DAD. Heptad breaks in α̃helical coiled coils: Stutters and stammers. Proteins 1996; 26:134-145. (Pubitemid 26365307)
31. Strelkov SV, Herrmann H, Geisler N et al. Conserved segments 1A and 2B of the intermediate filamentdimer: their atomic structures and role in filament assembly. EMBO J 2002; 21:1255-1266. (Pubitemid 34246505)
32. Strelkov SV, Burkhard P. Analysis of α̃helical coiled coils with the program TWISTER reveals a structural mechanism for stutter compensation. J Struct Biol 2002; 137:54-64. (Pubitemid 35430421)
33. Herrmann H, Strelkov SV, Feja B et al. The intermediate filament protein consensus motif of helix 2B: Its atomic structure and contribution to assembly. J Mol Biol 2000; 298:817-832.
34. Herrmann H, Haner M, Brettel M et al. Structure and assembly properties of the intermediate filament protein vimentin: The role of its head, rod and tail domains. J Mol Biol 1996; 264:933-953. (Pubitemid 27019484)
35. Heimburg T, Schuenemann J, Weber K et al. Specific recognition of coiled coils by infrared spectroscopy: Analysis of the three structural domains of type III intermediate filament proteins. Biochemistry 1996; 35:1375-1382. (Pubitemid 26055273)
36. Rogers KR, Eckelt A, Nimmrich V et al. Truncation mutagenesis of the non-alpha-helical carboxyterminal tail domain of vimentin reveals contributions to cellular localization but not to filament assembly. Eur J Cell Biol 1995; 66:136-150.
37. Arbustini E, Pasotti M, Pilotto A et al. Desmin accumulation restrictive cardiomyopathy and atrioventricular block associated with desmin gene defects. Eur J Heart Fail 2006; 8:477-483. (Pubitemid 44226451)
38. Taylor MRG, Slavov D, Ku L et al. Prevalence of desmin mutations in dilated cardiomyopathy. Circulation 2007; 115:1244-1251. (Pubitemid 46594768)
39. Bowles NE, Jimenez S, Vatta M et al. Familial restrictive cardiomyopathy caused by a missense mutation in the desmin gene. Pediatric Res 2002; 51:Suppl, p 2, abstract #1304. ]
40. Goudeau B, Rodrigues-Lima F, Fischer D et al. Variable pathogenic potentials of mutations located in the desmin alpha-helical domain. Hum Mutat 2006; 27:906-913. (Pubitemid 44336940)
41. Bushby et al. Genotype-morphotype correlations in myofibrillar myopathies. In preparation.
42. Schröder R, Goudeau B, Casteras-Simon M et al. On noxious desmin: Functional effects of a novel heterozygous desmin insertion mutation on the extrasarcomeric desmin cytoskeleton and mitochondria. Hum Mol Genet 2003; 12:657-669. (Pubitemid 36372492)
43. Vrabie A, Goldfarb LG, Shatunov A et al. Th e enlarging s spectrum of desminopathies: New morphological findings, eastward geographic spread, novel exon 3 desmin mutation. Acta Neuropathol (Berl) 2005; 109:411-417. (Pubitemid 40637315)
44. Shatunov A, Dalakas MC, Park K-Y et al. Desmin splice variants causing cardiac and skeletal myopathy. Amer J Hum Genet 2003; 73:Suppl, Abstract.
45. Yuri T, Miki K, Tsukamoto R et al. Autopsy case of desminopathy involving skeletal and cardiac muscle. Pathol Int 2007; 57:32-36. (Pubitemid 44934917)
46. Bar H, Fischer D, Goudeau B et al. Pathogenic effects of a novel heterozygous R350P desmin mutation on the assembly of desmin intermediate filaments in vivo and in vitro. Hum Mol Gen 2005;14:1251-1260. (Pubitemid 40744485)
47. Fidzianska A, Kotowicz J, Sadowska M et al. A novel desmin R355P mutation causes cardiac and skeletal myopathy. Neuromuscul Disord 2005; 15:525-531. (Pubitemid 41033006)
48. Dagvadorj A, Goudeau B, Hilton-Jones D et al. Respiratory insufficiency in desminopathy patients caused by introduction of proline residues in desmin C-terminal α-helical segment. Muscle Nerve 2003; 27:669-675. (Pubitemid 36667475)
49. Kaminska A, Strelkov SV, Goudeau B et al. Small deletions disturb desmin architecture leading to breakdown of muscle cells and development of skeletal or cardioskeletal myopathy. Hum Genet 2004; 114:306-313. (Pubitemid 38208310)
50. OlivürM, Armstrong J, Miralles F et al. Phenotypic patterns of desminopathy associated with three novel mutations in the desmin gene. Neuromuscul Disord 2007; 17:443-450. (Pubitemid 46783446)
51. Arias M, Pardo J, Blanco-Arias P et al. Distinct phenotypic features and gender-specifififififififi c disease manifestations in a Spanish family with desmin L370P mutation. Neuromuscul Disord 2006; 16:498-503. (Pubitemid 44332922)
52. Sugawara M, Kato K, Komatsu M et al. A novel de novo mutation in the desmin gene causes desmin myopathy with toxic aggregates. Neurology 2000; 55:986-990.
53. Goudeau B, Dagvadorj A, Rodrigues-Lima F et al. Structural and functional analysis of a new desmin variant causing desmin-related myopathy. Hum Mutat 2001; 18:388-396. (Pubitemid 33055008)
54. Dagvadorj A, OlivürM, Urtizberea J-A et al. West European cluster of patients with severe cardioskeletal myopathy associated with a de novo R406W mutation in desmin. J Neurol 2004, 251:143-149. (Pubitemid 38221626)
55. Pruszczyk P, Kostera-Pruszczyk A, Shatunov A et al. Restrictive cardiomyopathy with atrioventricular conduction block resulting from a desmin mutation. Int J Cardiol 2006; 117:244-253.
56. Bar H, Goudeau B, Walde S et al. Conspicuous involvement of desmin tail mutations in diverse cardiac and skeletal myopathies. Human Mut 2007; 28:374-386. (Pubitemid 46542924)
57. Li D, Tapscoft T, Gonzalez O et al. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 1999; 100:461-464. (Pubitemid 29360152)
58. Dalakas MC, Dagvadorj A, Goudeau B et al. Progressive skeletal myopathy, a phenotypic variant of desmin myopathy associated with desmin mutations. Neuromusc Disord 2003; 13:252-258. (Pubitemid 36279430)
59. Miyamoto Y, Akita H, Shiga N et al. Frequency and clinical characteristics of dilated cardiomyopathy caused by desmin gene mutation in a Japanese population. Eur Heart J 2001; 22:2284-2289. (Pubitemid 34000984)
60. Muntoni F, Bonne G, Goldfarb LG et al. Disease severity in dominant Emery Dreifuss is increased by mutations in both emerin and desmin proteins. Brain 2006; 129:1260-1268.
61. Bar H, Mucke N, Kostareva A et al. Severe muscle disease-causing desmin mutations interfere with in vitro filament assembly at distinct stages. Proc Natl Acad Sci USA. 2005;102:15099-15104. (Pubitemid 41513341)
62. Bang ML, Gregorio C, Labeit S. Molecular dissection of the interaction of desmin with the C-terminal region of nebulin. J Struct Biol 2002; 137:119-127. (Pubitemid 35430427)
63. MacArthur MW, Thornton JM. Influence of proline residues on protein conformation. J Mol Biol 1991; 218:397-412. (Pubitemid 121003355)
64. Raats JMH, Henderik JBJ, Verdijk M et al. Assembly of carboxy-terminally deleted desmin in vimentin- free cells. Eur J Cell Biol 1991; 56:84-103.
65. Brakenhoff RH, Guerts van Kessel AH et al. Human alpha B-crystallin (CRYA2) gene mapped to chromosome 11q12-q23. Hum Genet 1990; 85:237-240. (Pubitemid 20222578)
66. Dubin RA, Ally AH, Chung S et al. Human alpha-B-crystallin gene and preferential promoter function in lens. Genomics 1990; 7:594-601. (Pubitemid 20244464)
67. Horwitz J. The function of alpha-crystallin in vision. Semin Cell Dev Biol 2000; 11:53-60. (Pubitemid 32098002)
68. Golenhofen N, Htun P, Ness W et al. Binding of the stress protein alpha B-crystallin to cardiac myofibrils correlates with the degree of myocardial damage during ischemia/reperfusion in vivo. J Mol Cell Cardiol 1999; 31:569-580. (Pubitemid 29121643)
69. Martin JL, Mestril R, Hilal-Dandan R et al. Small heat shock proteins and protection against ischemic injury in cardiac myocytes. Circulation 1997; 96:4343-4348. (Pubitemid 28007464)
70. Hahner A, Erdmann J, Kallisch H et al. Five novel genetic variants in the promoter and coding region of the alphaB-crystallin gene (CRYAB): -652G>A, -650C>G, -249G>C, S41Y, P51L. Hum Mutat 2000; 16:374-377.
71. Fardeau M, Godet-Guillain J, Tome FM et al. Une nouvelle affection musculaire familiale, definie par laccumulation intra-sarco-plasmique dun materiel granulo-filamentaire dense en microscopie electronique. Rev Neurol 1978 ; 134:411-425. (Pubitemid 9010013)
72. Bova MP, Yaron O, Huang Q et al. Mutation R120G in aB-crystallin, which is linked to a desmin-related myopathy, results in an irregular structure and defective chaperone-like function. Proc Natl Acad Sci USA 1999; 96:6137-6142. (Pubitemid 29256632)
73. Chavez Zobel AT, Loranger A, Marceau N et al. Distinct chaperone mechanisms can delay the formation of aggresomes by the myopathy-causing R120G alpha-B-crystallin mutant. Hum Molec Genet 2003; 12:1609-1620. (Pubitemid 36857307)
74. Fu L, Liang JJ-N. Alteration of protein-protein interactions of congenital cataract crystallin mutants. Invest Ophthal Vis Sci 2003; 44:1155-1159. (Pubitemid 36297835)
75. Selcen D, Engel AG. Myofibrillar myopathy caused by novel dominant negative alpha-B-crystallin mutations. Ann Neurol 2003; 54:804-810. (Pubitemid 37498963)
76. Berry V, Francis P, Reddy MA et al. Alpha-B crystallin gene (CRYAB) mutation causes dominant congenital posterior polar cataract in humans. Am J Hum Genet 2001; 69:1141-1145. (Pubitemid 33015828)
77. Liu M, Ke T, Wang Z et al. Identification of a CRYAB mutation associated with autosomal dominant posterior polar cataract in a Chinese family. Invest Ophthalmol Vis Sci 2006; 47:3461-3466. (Pubitemid 351639711)
78. Nakano S, Engel AG, Waclawik AJ et al. Myofibrillar myopathy with abnormal foci of desmin positivity. Light and electron microscopy analysis of 10 cases. J Neuropathol Exp Neurol 1996; 55:549-562. (Pubitemid 26140838)
79. Bar H, Kostareva A, Sjoberg G et al. Forced expression of desmin and desmin mutants in cultured cells: Impact of myopathic missense mutations in the central coiled-coil domain on network formation. Exp Cell Res 2006; 312:1554-1565.
80. Herrmann H, Aebi U. Intermediate filaments: Molecular structure, assembly mechanism and integration into functionally distinct intracellular scaffolds. Annu Rev Biochem 2004; 73:749-789. (Pubitemid 39050385)
81. Thornell L-E, Carlsson L, Mericskay M et al. Null mutation in the desmin gene gives rise to a cardiomyopathy. J Mol Cell Cardiol 1997; 29:2107-2124. (Pubitemid 27348522)
82. Li M, Dalakas MC. Abnormal desmin protein in myofibrillar myopathies caused by desmin gene mutations. Desmin protein in myofibrillar myopathies. Ann Neurol 2001; 49:532-536.
83. Bar H, Mucke N, Ringler P et al. Impact of disease mutations on the desmin filament assembly process. J Mol Biol 2006; 360:1031-1042. (Pubitemid 44062518)
84. Raats JM, Schaart G, Henderik JB et al. Muscle-specific expression of a dominant negative desmin mutant in transgenic mice. Eur J Cell Biol 1996; 71:221-236. (Pubitemid 26388418)
85. Carlsson L, Fischer C, Sjoberg G et al. Cytoskeletal derangements in hereditary myopathy with a desmin L345P mutation. Acta Neuropathol 2002; 104:493-504. (Pubitemid 36075417)
86. Agbulut O, Li Z, Mouly V et al. Analysis of skeletal and cardiac muscle from desmin knock-out and normal mice by high resolution separation of myosin heavy-chain isoforms. Biol Cell 1996; 88:131-135. (Pubitemid 126820243)
87. Paulin D, Huet A, Khanamyrian L et al. Desminopathies in muscle disease. J Pathol 2004; 204:418-427. (Pubitemid 39468153)
88. Yu KR, Hijikata T, Lin ZX et al. Truncated desmin in PtK2 cells induces desmin-vimentin-cytokeratin coprecipitation, involution of intermediate filament networks and nuclear fragmentation: A model for many degenerative diseases. Proc Natl Acad Sci USA 1994; 91:2497-2501.
89. Perng MD, Muchowski PJ, van den Ijssel P et al. The cardiomyopathy and lens cataract mutation in alpha B-crystallin alters its protein structure, chaperone activity and interaction with intermediate filaments in vitro. J Biol Chem 1999, 274:33235-33243. (Pubitemid 129511621)
90. Wang X, Osinska H, Gerdes AM et al. Desmin filaments and cardiac disease: Establishing causality. J Cardiac Failure 2002; 8:S287-S292. (Pubitemid 36083073)
91. Sanbe A, Osinska H, Saffitz JE et al. Desmin-related cardiomyopathy in transgenic mice: A cardiac amyloidosis. Proc Natl Acad Sci USA 2004; 101:10132-10136. (Pubitemid 38891207)
92. Sanbe A, Osinska H, Villa C et al. Reversal of amyloid-induced heart disease in desmin-related cardiomyopathy. Proc Natl Acad Sci USA 2005; 102:13592-13597. (Pubitemid 41420893)
93. Nakano S, Engel AG, Akiguchi I et al. Myofibrillar myopathy. III. Abnormal expression of cyclindependent kinases and nuclear proteins. J Neuropathol Exp Neurol 1997; 56:850-856. (Pubitemid 27329105)
94. Caron A, Chapon F. Desmin phosphorylation abnormalities in cytoplasmic body and desmin-related myopathies. Muscle Nerve 1999; 22:1122-1125. (Pubitemid 29360259)
95. Rappaport L, Contard F, Samuel JL et al. Storage of phosphorylated desmin in a familial myopathy. FEBS Lett 1988; 231:421-415.
96. Dalakas MC, Vasconcelos OM, Kaminska A et al. Desmin myopathy: Distinct filamentopathy caused by mutations in the desmin gene. Acta Myologica 2002; 21:138-143. (Pubitemid 36286116)
97. OlivürM, Goldfarb L, Moreno D et al. Desmin-related myopathy: C Clinical, electrophysiological, radiological, neuropathological and genetic studies. J Neurol Sci 2004; 219:125-137. (Pubitemid 38406008)
98. Boriek AM, Capetanaki Y, Hwang W et al. Desmin integrates the three-dimensional mechanical properties of muscles. Am J Physiol Cell Physiol 2001; 280:C46-C52.
99. Towbin JA, Bowles NE. The failing heart. Nature 2002; 415:227-233. (Pubitemid 34059529)
100. Takeda N. Cardiomyopathy: Molecular and immunological aspects (review). Int J Mol Med 2003; 11:13-16.
101. Horowitz SH, Schmalbruch H. Autosomal dominant distal myopathy with desmin storage: a clinicopathologic and electrophysiologic study of a large kinship. Muscle Nerve 1994; 17:151-160. (Pubitemid 24040219)
102. Ariza A, Coll J, Fernandez-Figueras MT et al. Desmin myopathy: A multisystem disorder involving skeletal, cardiac and smooth muscle. Hum Pathol 1995; 26:1032-1037.
103. Fardeau M, Vicart P, Caron A et al. Myopathie familiale avec surcharge en desmine, sous forme de matéiel granulo-filamentaire dense en microscopie éectronique, avec mutation dans le gèe de lalpha- B-cristalline. Rev Neurol (Paris) 2000; 156: 497-504. (Pubitemid 30390010)
104. Goebel HH. Desmin-related neuromuscular disorders. Muscle Nerve 1995; 18:1306-1320.
105. Sarnat HB. Vimentin and desmin in maturing skeletal muscle and developmental myopathies. Neurology 1992; 42:1616-1624.
106. Thornell LE, Edstrom L, Eriksson A et al. The distribution of intermediate filament protein (skeletin) in normal and diseased human skeletal muscle-An immunohistochemical and electron-microscopic study. J Neurol Sci 1980; 47:153-170. (Pubitemid 10046294)
107. Askanas V, Bornemann A, Engel WK. Immunocytochemical localization of desmin at human neuromuscular junction. Neurology 1990; 40:949-953. (Pubitemid 20201822)
108. Tidball JC. Desmin at myotendinous junctions. Exp Cell Res 1992; 199:341-348.
109. Howman EV, Sullivan N, Poon EP et al. Syncoilin accumulation in two patients with desmin-related myopathy. Neuromuscul Disord 2003; 13:42-48. (Pubitemid 35430138)
110. Engel AG. Myofibrillar myopathy. Ann Neurol 1999; 46:681-683. (Pubitemid 29518127)
111. Selcen D, Engel AG. Mutations in myotilin cause myofibrillar myopathy. Neurology 2004; 62:1363-1371. (Pubitemid 38526050)
112. OlivürM, Goldfarb LG, Shatunov A et al. Myotilinopathy: Refining the clinical and myopathological phenotype. Brain 2005; 128: 2315-2326. (Pubitemid 41407972)
113. +1) and p62 in myotilinopathies and desminopathies. Neuropathol Appl Neurobiol 2007, in press.
114. Fischer D, Clamen CS, OlivürM et al. Different early patogenesis in myotilinopathy compared to primary desminopathy. Neuromuscul Disord 2006; 16: 361-367. (Pubitemid 43884789)
115. Selcen D, Engel AG. Mutations in ZASP define a novel form of muscular dystrophy in humans. Ann Neurol 2005; 57:269-276. (Pubitemid 40179865)
116. Penisson-Besnier I, Talvinen K, Dumez C et al. Myotilinopathy in a family with late onset myopathy. Neuromuscul Disord 2006; 16:427-431. (Pubitemid 44094099)
117. Ferreiro A, Ceuterick-de Groote C et al. Desmin-related myopathy with Mallory body-like inclusions is caused by mutations of the selenoprotein N gene. Ann Neurol 2004; 55:676-686. (Pubitemid 38544328)
118. Vorgerd M, van der Ven PF, Bruchertseifer V et al. A mutation in the dimerization domain of filamin C causes a novel type of autosomal dominant myofibrillar myopathy. Am J Hum Genet 2005; 77:297-304. (Pubitemid 41022711)
119. Hürbers CU, Clemen CS, Kesper K et al. Pathological consequences of VCP mutations on human striated muscle. Brain 2007; 130:381-393. (Pubitemid 46181092)